نتایج جستجو برای: fgfr2

تعداد نتایج: 1274  

2015
Jinjia Chang Shanshan Wang Zhe Zhang Xinyang Liu Zheng Wu Ruixuan Geng Xiaoxiao Ge Congqi Dai Rujiao Liu Qunling Zhang Wenhua Li Jin Li

Fibroblast growth factor receptor 2 (FGFR2)-targeted therapy has attracted considerable attention as novel anticancer agents in gastric cancer (GC). However, intrinsic or acquired drug resistance has emerged as a major challenge to their clinical use. In this study, we demonstrated that several receptor tyrosine kinase (RTK), including EGFR, HER3 and MET, activations contributed to AZD4547 (a s...

2014
Mitesh J. Borad Mia D. Champion Jan B. Egan Winnie S. Liang Rafael Fonseca Alan H. Bryce Ann E. McCullough Michael T. Barrett Katherine Hunt Maitray D. Patel Scott W. Young Joseph M. Collins Alvin C. Silva Rachel M. Condjella Matthew Block Robert R. McWilliams Konstantinos N. Lazaridis Eric W. Klee Keith C. Bible Pamela Harris Gavin R. Oliver Jaysheel D. Bhavsar Asha A. Nair Sumit Middha Yan Asmann Jean-Pierre Kocher Kimberly Schahl Benjamin R. Kipp Emily G. Barr Fritcher Angela Baker Jessica Aldrich Ahmet Kurdoglu Tyler Izatt Alexis Christoforides Irene Cherni Sara Nasser Rebecca Reiman Lori Phillips Jackie McDonald Jonathan Adkins Stephen D. Mastrian Pamela Placek Aprill T. Watanabe Janine LoBello Haiyong Han Daniel Von Hoff David W. Craig A. Keith Stewart John D. Carpten

Advanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced cholangiocarcinoma. Integrated genome-wide and whole transcriptome sequence analyses were performed on tumors from six patients with advanced, sporadic ...

2014
Florian Meier Florian Giesert Sabit Delic Theresa Faus-Kessler Friederike Matheus Antonio Simeone Sabine M. Hölter Ralf Kühn Daniela M. Vogt. Weisenhorn Wolfgang Wurst Nilima Prakash

The normal cellular organization and layering of the vertebrate cerebellum is established during embryonic and early postnatal development by the interplay of a complex array of genetic and signaling pathways. Disruption of these processes and of the proper layering of the cerebellum usually leads to ataxic behaviors. Here, we analyzed the relative contribution of Fibroblast growth factor recep...

2014
Mark Greenfield M. Greenfield

A closed hyperbolic Riemann surfaceM is said to beK-quasiconformally homogeneous if there exists a transitive family F of K-quasiconformal homeomorphisms. Further, if all [f ] ⊂ F act trivially on H1(M ;Z), we say M is Torelli-K-quasiconformally homogeneous. We prove the existence of a uniform lower bound on K for Torelli-K-quasiconformally homogeneous Riemann surfaces. This is a special case o...

2016
Rahem Khoshbakht Mohammad Tabatabaei Saeid Hoseinzadeh Mojtaba Mojtaba Hesamaddin Shirzad Aski Enayat Berizi

The receptors 1 and 2 of fibroblast growth factor (FGFR1 and FGFR2, respectively) have been observed in all types of testicular cells. Culture on extracellular matrix (ECM) has been observed to lead to initiation of differentiation in spermatogonial stem cells (SSCs). The present study was carried out to investigate whether FGFR1 and FGFR2 play a role in SSCs differentiation. Following isolatio...

Journal: :Mechanisms of Development 2009
Wen-Pin Wang Da-Wei Liu

Previously, we identified Fgfr2 as the major Fgf receptor in liver specification. Expression of Hhex in the liver was reduced in Fgfr2 morphants. Unexpectedly, we found the relative position of the liver and pancreas were disrupted. In addition to visceral organs, we found the heart was randomized in Fgfr2 morphants. Expression patterns of genes controlling laterality including Spaw, lefty1 and...

Journal: :American journal of physiology. Heart and circulatory physiology 2016
Stacey L House Angela M Castro Traian S Lupu Carla Weinheimer Craig Smith Attila Kovacs David M Ornitz

Fibroblast growth factor (FGF) signaling is cardioprotective in various models of myocardial infarction. FGF receptors (FGFRs) are expressed in multiple cell types in the adult heart, but the cell type-specific FGFR signaling that mediates different cardioprotective endpoints is not known. To determine the requirement for FGFR signaling in endothelium in cardiac ischemia-reperfusion injury, we ...

2009
Kingyin Michael Arthur Lee

Fibroblast Growth Factor (FGF) and Transforming Growth Factor beta (TGFbeta) are key regulators of bone development. Constitutively activating mutations of FGF Receptors (FGFR) 1-3 result in craniosynostosis, premature fusion of cranial sutures. The aim of this thesis was to determine how FGF signalling is impaired in osteoblasts with the mutation FGFR2-C278F, known to induce craniosnostosis an...

2017
Rebecca Higgins Andrew Pink Robert Hunger Nikhil Yawalkar Alexander A. Navarini

Mutations in the fibroblast growth factor-receptor gene 2 (FGFR2) gene have been implicated in numerous diseases, including nevus comedonicus (NC) and naevoid acne that have somatic missense mutations in FGFR2 in the affected tissue. A patient presented in our department with unusual, innumerable large comedones throughout his back reminiscient of NC, as well as multifocal hidradenitis suppurat...

Journal: :Cancer research 2014
Jeremy H Tchaicha Esra A Akbay Abigail Altabef Oliver R Mikse Eiki Kikuchi Kevin Rhee Rachel G Liao Roderick T Bronson Lynette M Sholl Matthew Meyerson Peter S Hammerman Kwok-Kin Wong

Somatic mutations in FGFR2 are present in 4% to 5% of patients diagnosed with non-small cell lung cancer (NSCLC). Amplification and mutations in FGFR genes have been identified in patients with NSCLCs, and clinical trials are testing the efficacy of anti-FGFR therapies. FGFR2 and other FGFR kinase family gene alterations have been found in both lung squamous cell carcinoma and lung adenocarcino...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید